// App-Quantinova.ai

P1385 : THE GUIDING SIGNIFICANCE OF IMMUNE CELL SUBSET MONITORING IN IMMUNE RECONSTITUTION IN PATIENTS WITH CAR-T BRIDGED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Researchers

Presenter

  • wei zhao

Principal Investigators

  • man chen

  • yanyan an

  • Peijuan hu

  • Meihua chen

  • Hui Wang

  • peihua Lu

  • yanli zhao

Medical Centers

  • clini

  • beijing Lu daopei hospital,beijing,Chine

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,Cina

  • beijing Lu daopei hospital,beijing,Chine

  • Hebei Yanda Lu Daopei Hospital, Langfang, China

  • Hebei Yanda Lu Daopei Hospital, Langfang, China

  • beijing Lu daopei hospital,beijing,Chine

  • beijing Lu daopei hospital,beijing,Chine

  • Hebei Yanda Lu Daopei Hospital, Langfang, China

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,China

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,Cina

  • Hebei Yanda Lu Daopei Hospital

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved